Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: 749 Patent Reexam Terminated NIRC to follow/ MMP Reex status

Out of 16 reexaminations requests at USPTO there are only 2 merged from 4 requests remaining;

'148 (90/008,227) (90/010,562) MERGED

STATUS: Response after Non final Action received Sept. 29, 2010

'584 (90/011,169)(90/009,591) MERGED

STATUS: Non Final Action mailed Jan. 13, 2011

------------------------------------------------------------------------------------------

NIRC'd, Recerted or Denied

'336 (90/008,237)(90/008,306)(90/008,474) MERGED - RECERT

(90/009,457) - RECERT

(90/010,551) - DENIED

(90/011,168) - DENIED

'584 (90/008,225) - RECERT

(90/008,591) - DENIED

'749 (90/009,034)(90/009,389)(90/010,520) MERGED - NIRC

'890 (90/009,388) - NIRC

-----------------------------------------------------------------------------------------

Also the validity of EP'730 (MMP European equivalent) was upheld by German Federal Patent Court

GLTAL

Share
New Message
Please login to post a reply